Crossmark

Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment

Published Online: 2021-09-16

Published Print: 2021-12

Authors

Terai, Shuji https://orcid.org/0000-0002-5439-635X
Tsuchiya, Atsunori

Watanabe, Yusuke

Takeuchi, Suguru
Funding

Funding for this research was provided by:

rohto pharmaceutical co., ltd.
License Information

Text and Data Mining valid from 2021-09-16

Version of Record valid from 2021-09-16
More Information

Article History

Received: 8 July 2021

Accepted: 6 September 2021

First Online: 16 September 2021

Declarations

:

: N/A.

: N/A.

: ST received research fund from ROHTO Pharmaceutical Co., Ltd. ROHTO Pharmaceutical Co., Ltd. supports a clinical trial of MSCs.

Document is current